» Articles » PMID: 24577545

Splenectomy for Children With Thalassemia: Total or Partial Splenectomy, Open or Laparoscopic Splenectomy

Overview
Specialty Pediatrics
Date 2014 Mar 1
PMID 24577545
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Splenomegaly and hypersplenism are common complications among children with thalassemia necessitating splenectomy. Thirty-six children (27 β-thalassemia major, 3 Hb H disease, and 6 thalassemia intermediate) had total splenectomy (11 laparoscopic and 13 open splenectomy) or partial splenectomy (12 patients). In the partial splenectomy group, 2 with Hb H required no transfusions. For those with β-thalassemia major who had partial splenectomy (9 patients), there was a reduction in the number of transfusions from a preoperative mean of 15.2 transfusions per year to a postoperative mean of 8.2 transfusions per year. Subsequently and as a result of increase in the size of splenic remnant, their transfusions increased, but none required total splenectomy. Twenty-four patients had total splenectomy (13 open and 11 laparoscopic splenectomy). Their postsplenectomy transfusions decreased from a preoperative mean of 17.8 transfusions per year to a postoperative mean of 10 transfusions per year. There was no mortality, and none developed postoperative sepsis or thrombotic complications. Total splenectomy is beneficial for children with β-thalassemia major and hypersplenism by reducing their transfusion requirements. Laparoscopic splenectomy is however more beneficial. Partial splenectomy reduces their transfusion requirements, but only as a temporary measure, and so it is recommended for children younger than 5 years of age.

Citing Articles

Beta Thalassemia in Children: Established Approaches, Old Issues, New Non-Curative Therapies, and Perspectives on Healing.

Origa R, Issa L J Clin Med. 2024; 13(22).

PMID: 39598110 PMC: 11594693. DOI: 10.3390/jcm13226966.


Clinical comparative study of laparoscopic partial splenectomy and open partial splenectomy.

Zeng S, Wang W, Chen W, Xiao J Wideochir Inne Tech Maloinwazyjne. 2024; 19(2):211-222.

PMID: 38973786 PMC: 11223557. DOI: 10.5114/wiitm.2024.139988.


Epidemiology and treatment of beta thalassemia major in China.

Xu X, Wu X Pediatr Investig. 2020; 4(1):43-47.

PMID: 32851341 PMC: 7331292. DOI: 10.1002/ped4.12154.


Splenectomy for people with thalassaemia major or intermedia.

Sharma A, Easow Mathew M, Puri L Cochrane Database Syst Rev. 2019; 9:CD010517.

PMID: 31529486 PMC: 6746994. DOI: 10.1002/14651858.CD010517.pub3.


The effect of splenectomy on complement regulatory proteins in erythrocytes in β-thalassemia major.

Kurtogllu A, Koctekin B, Kurtoglu E, Yildiz M Arch Med Sci. 2019; 15(1):191-195.

PMID: 30697270 PMC: 6348341. DOI: 10.5114/aoms.2018.81036.